for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AstraZeneca's COVID-19 cocktail clears first step for registration in Australia

Nov 9 (Reuters) - Australia’s medical regulator said on Tuesday it had granted provisional determination to AstraZeneca for its antibody cocktail, the first protective shot other than vaccines against the COVID-19.

The Therapeutic Goods Administration added bit.ly/3D0SOuH that the Anglo-Swedish drugmaker is now eligible to apply for provisional registration for the antibody cocktail, EVUSHELD, in Australia.

Reporting by Indranil Sarkar in Bengaluru; Editing by Sherry Jacob-Phillips

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up